129 related articles for article (PubMed ID: 23756023)
1. The role of prostaglandin E2 in human vascular inflammation.
Gomez I; Foudi N; Longrois D; Norel X
Prostaglandins Leukot Essent Fatty Acids; 2013 Aug; 89(2-3):55-63. PubMed ID: 23756023
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances.
Legler DF; Bruckner M; Uetz-von Allmen E; Krause P
Int J Biochem Cell Biol; 2010 Feb; 42(2):198-201. PubMed ID: 19788928
[TBL] [Abstract][Full Text] [Related]
3. Cyclooxygenase-2-dependent prostaglandin (PG) E2 downregulates matrix metalloproteinase-3 production via EP2/EP4 subtypes of PGE2 receptors in human periodontal ligament cells stimulated with interleukin-1alpha.
Yan M; Noguchi K; Ruwanpura SM; Ishikawa I
J Periodontol; 2005 Jun; 76(6):929-35. PubMed ID: 15948687
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of vasodilatory prostaglandins on focal adhesions, cytoskeletal architecture, and migration in human aortic smooth muscle cells.
Bulin C; Albrecht U; Bode JG; Weber AA; Schrör K; Levkau B; Fischer JW
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):84-9. PubMed ID: 15458982
[TBL] [Abstract][Full Text] [Related]
5. [Prostaglandin(PG) E2 in regulation of immunity and inflammatory diseases].
Xue R; Miao YF; Yang JC; Guan YF
Sheng Li Ke Xue Jin Zhan; 2011 Jun; 42(3):165-8. PubMed ID: 21932512
[TBL] [Abstract][Full Text] [Related]
6. The cyclooxygenase-2-prostaglandin E2 pathway maintains senescence of chronic obstructive pulmonary disease fibroblasts.
Dagouassat M; Gagliolo JM; Chrusciel S; Bourin MC; Duprez C; Caramelle P; Boyer L; Hue S; Stern JB; Validire P; Longrois D; Norel X; Dubois-Randé JL; Le Gouvello S; Adnot S; Boczkowski J
Am J Respir Crit Care Med; 2013 Apr; 187(7):703-14. PubMed ID: 23328527
[TBL] [Abstract][Full Text] [Related]
7. Intracellular measurement of prostaglandin E2: effect of anti-inflammatory drugs on cyclooxygenase activity and prostanoid expression.
Horton JK; Williams AS; Smith-Phillips Z; Martin RC; O'Beirne G
Anal Biochem; 1999 Jun; 271(1):18-28. PubMed ID: 10361000
[TBL] [Abstract][Full Text] [Related]
8. Targeting PGE2 receptor subtypes rather than cyclooxygenases: a bridge over troubled water?
Rocca B
Mol Interv; 2006 Apr; 6(2):68-73, 58. PubMed ID: 16565468
[TBL] [Abstract][Full Text] [Related]
9. Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13.
Trudeau J; Hu H; Chibana K; Chu HW; Westcott JY; Wenzel SE
J Allergy Clin Immunol; 2006 Jun; 117(6):1446-54. PubMed ID: 16751012
[TBL] [Abstract][Full Text] [Related]
10. EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries.
Jadhav V; Jabre A; Lin SZ; Lee TJ
J Cereb Blood Flow Metab; 2004 Dec; 24(12):1305-16. PubMed ID: 15625406
[TBL] [Abstract][Full Text] [Related]
11. Sodium butyrate induces the production of cyclooxygenases and prostaglandin E₂ in ROS 17/2.8 osteoblastic cells.
Iida T; Kawato T; Tanaka H; Tanabe N; Nakai K; Zhao N; Suzuki N; Ochiai K; Maeno M
Arch Oral Biol; 2011 Jul; 56(7):678-86. PubMed ID: 21281931
[TBL] [Abstract][Full Text] [Related]
12. Inflammation increases MMP levels via PGE
Ozen G; Boumiza S; Deschildre C; Topal G; Longrois D; Jakobsson PJ; Michel JB; Jacob MP; Chahed K; Norel X
Int J Obes (Lond); 2019 Sep; 43(9):1724-1734. PubMed ID: 30349011
[TBL] [Abstract][Full Text] [Related]
13. Dominant role of prostaglandin E2 EP4 receptor in furosemide-induced salt-losing tubulopathy: a model for hyperprostaglandin E syndrome/antenatal Bartter syndrome.
Nüsing RM; Treude A; Weissenberger C; Jensen B; Bek M; Wagner C; Narumiya S; Seyberth HW
J Am Soc Nephrol; 2005 Aug; 16(8):2354-62. PubMed ID: 15976003
[TBL] [Abstract][Full Text] [Related]
14. Involvement of cyclooxygenase-derived prostaglandin E2 and nitric oxide in the protection of rat pancreas afforded by low dose of lipopolysaccharide.
Jaworek J; Bonior J; Tomaszewska R; Jachimczak B; Kot M; Bielański W; Pawlik WW; Sendur R; Stachura J; Konturek PC; Konturek SJ
J Physiol Pharmacol; 2001 Mar; 52(1):107-26. PubMed ID: 11321505
[TBL] [Abstract][Full Text] [Related]
15. Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer.
Murphey LJ; Williams MK; Sanchez SC; Byrne LM; Csiki I; Oates JA; Johnson DH; Morrow JD
Anal Biochem; 2004 Nov; 334(2):266-75. PubMed ID: 15494133
[TBL] [Abstract][Full Text] [Related]
16. IL-1beta stimulates the expression of prostaglandin receptor EP4 in human chondrocytes by increasing production of prostaglandin E2.
Watanabe Y; Namba A; Honda K; Aida Y; Matsumura H; Shimizu O; Suzuki N; Tanabe N; Maeno M
Connect Tissue Res; 2009; 50(3):186-93. PubMed ID: 19444759
[TBL] [Abstract][Full Text] [Related]
17. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells.
Arikawa T; Omura K; Morita I
J Cell Physiol; 2004 Sep; 200(3):400-6. PubMed ID: 15254968
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandins and chronic inflammation.
Aoki T; Narumiya S
Trends Pharmacol Sci; 2012 Jun; 33(6):304-11. PubMed ID: 22464140
[TBL] [Abstract][Full Text] [Related]
19. Vascular wall-produced prostaglandin E2 exacerbates arterial thrombosis and atherothrombosis through platelet EP3 receptors.
Gross S; Tilly P; Hentsch D; Vonesch JL; Fabre JE
J Exp Med; 2007 Feb; 204(2):311-20. PubMed ID: 17242161
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin induces prostaglandin E2 release in vascular endothelial cells.
Matsunuma S; Handa S; Kamei D; Yamamoto H; Okuyama K; Kato Y
Cancer Chemother Pharmacol; 2019 Aug; 84(2):345-350. PubMed ID: 31243527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
